Updated Jul 16, 2026
Friberg Gregory R has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $559K.
Gregory R. Friberg is an executive at BioMarin Pharmaceutical Inc., serving as the Executive Vice President and Chief Research and Development Officer. He has been involved in the biotechnology sector, focusing on therapies for rare genetic diseases.
| Role | EVP, Chief R&D Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-11 | BMRN | BIOMARIN PHARMACEUTICAL INC | S — Open-market sale | 3.3K | $53.85 | $177K |
| 2026-03-18 | BMRN | BIOMARIN PHARMACEUTICAL INC | F — Tax withholding / forfeiture | 1.6K | $56.05 | $91K |
| 2026-03-18 | BMRN | BIOMARIN PHARMACEUTICAL INC | A — Grant or award | 19.1K | $0.00 | |
| 2026-02-27 | BMRN | BIOMARIN PHARMACEUTICAL INC | S — Open-market sale | 6.3K | $60.38 | $382K |
| 2025-09-30 | BMRN | BIOMARIN PHARMACEUTICAL INC | F — Tax withholding / forfeiture | 3.3K | $54.16 | $179K |
| 2024-10-01 | BMRN | BIOMARIN PHARMACEUTICAL INC | A — Grant or award | 7.9K | $0.00 | |
| 2024-10-01 | BMRN | BIOMARIN PHARMACEUTICAL INC | A — Grant or award | 21.2K | $0.00 |
Gregory R. Friberg is an executive at BioMarin Pharmaceutical Inc., serving as the Executive Vice President and Chief Research and Development Officer. He has been involved in the biotechnology sector, focusing on therapies for rare genetic diseases.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($559K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Friberg Gregory R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.